Company Search:
Advanced Search
Sponsored Links
Altimmune Inc Company Snapshot
Altimmune Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Altimmune Inc with three other companies in this sector in the United States: Insmed Incorporated (2018 sales of $9.84 million of which 100% was Pharmaceutical Products), Unum Therapeutics Inc ($9.73 million of which 100% was Biopharmaceutical C), and Menlo Therapeutics Inc ($10.64 million of which 100% was operates in one segment).

Sales Analysis. Altimmune Inc reported sales of $10.33 million for the year ending December of 2018. This represents a decrease of 3.8% versus 2017, when the company's sales were $10.74 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Altimmune Inc
  Stock Performance Chart for Altimmune Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 1.84
(Figures in U.S. Dollars)
1 Week -0.5%   13 Weeks 4.5%  
4 Weeks -8.9%   52 Weeks -36.8%  
Altimmune Inc Key Data:
  Ticker: ALT Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 10,331,168
(Year Ending Jan 2019).
Employees: 27
  Currency: U.S. Dollars Market Cap: 28,222,052
  Fiscal Yr Ends: December Shares Outstanding: 15,338,072
  Share Type: Common Closely Held Shares: 916,751
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.